Recommendation of the Czech Society of Clinical Biochemistry: the use of cardiac troponins in suspected acute coronary syndrome

1. Thygesen, K., Alpert, J. S., Jaffe, A. S., Simons, M. L., Chaitman, B. R., White, H. S. et al. Third universal definition of myocardial infarction. Circulation, 2012,126, p. 2020-2035.

2. Barth, J. H., Panteghini, M., Bunk, D. H., Christenson, R. H., Katrukha, A. et al. Recommendation to harmonize the units for reporting cardiac troponin results. Clin. Chim. Acta, 2014, 432, p. 166.

3. Thygesen, K., Mair, J., Giannitis, E., Mueller, C., Lindahl, B., Blankenburg, S. et al. How to use high-sensitivity cardiac troponins in acute cardiac care (ESC ). Eur. Heart. J., 2012, 30, p. 2252-2257.

4. Apple, F. S., Jaffe, A. S., Collinson, P., Michel, M., Ordones-Llanos, J., Lindahl, B. et al. IFCC educational materials on the selected analytical and clinical applications of high sensitivity cardiac troponin assays. Clin. Biochem., 2015, 48, p. 201-203.

5. Jaffe, A. S., Vasile, V. C., Milone, M., Saenger, A. K., Olson, K. N., Apple, F. S. Diseased skeletal muscle: A Noncardiac source of increased circulating concentrations of cardiac troponin T. J. Am. Coll. Cardiol., 2011, 58, p. 1819–1824.

6. White, H. D. Pathobiology of troponin elevations: Do elevations occur with myocardial ischemia as well as Necrosis? J. Am. Coll. Cardiol., 2011, 57, p. 2406–2408.

7. Liebetrau, C., Möllmann, H., Nef, H., Szardien, S., Rixe, J., Troidl, C., Hamm, C. Release kinetics of cardiac biomarkers in patients undergoing transcoronary ablation of septal hypertrophy. Clin. Chem. 2012, 58, p. 1049–1054.

8. Solecki, K., Dupuy, A. M., Kuster, N., Leclercq, F., Gervasoni, R., Macia, J. C., Roubille, F. Kinetics of high-sensitivity cardiac troponin T or troponin I compared to creatine kinase in patients with revascularized acute myocardial infarction. Clin. Chem. Lab. Med, 2014. Doi:10.1515/cclm-2014-0475.

9. Daves, M., Salvagno, G. L., Cemin, R., Gelati, M., Cervellin, G., Guidi, G. C., Lippi, G. Influence of hemolysis on routine laboratory cardiac marker testing. Clin. Lab., 2012, 58, p. 333–336.

10. Bais, R. The Effect of Sample Hemolysis on Cardiac Troponin I and T Assays. Clin. Chem., 2010, 56, p. 1357–1359.

11. Aihong, L., Brattsand, G. Stability of serum samples and hemolysis interference on the high sensitivity troponin T assay. Clin. Chem. Lab. Med., 2011, 49, p. 335–336.

12. Wu, A. H. B., Shea, E. Lu Q. T., Minyard, J. Bui K., Hsu, J. C. Y., Todd, J. Short- and long-term cardiac troponin I analyte stability in plasma and serum from healthy volunteers by use of an ultrasensitive, single-molecule counting assay. Clin. Chem., 2009, 55, p. 2057–2059.

13. Nordenskjöld, A. M., Ahlström, H., Eggers, K. M., Fröbert, O., Jaffe, A. S., Venge, P., Lindahl, B. Short- and long-term individual variation in cardiac troponin in patients with stable coronary artery disease. Clin. Chem., 2013, 59, p. 401–409.

14. Klinkenberg, L. J. J., van Dijk, J. W., Tan, F. E. S., van Loon, L. J. C., van Dieijen-Visser, M. P., Meex, S. J. R. Circulating cardiac troponin T exhibits a diurnal rhythm. J. Am. Coll. Cardiol., 2014, 63, p. 1788–1795.

15. Aakre, K. M., Roraas, T., Petersen, P. H., Svarstad, E., Sellevoll, H., Skadberg, O., Sandberg, S. Weekly and 90-minute biological variations in cardiac troponin T and cardiac troponin I in hemodialysis patients and healthy controls. Clin. Chem., 2014, 60, p. 838–847.

16. Apple, F. S., Ler, R., Murakami, M. M. Determination of 19 Cardiac troponin I and T Assay 99. percentile Values from a Common Presumably healthy Population. Clin. Chem., 2012, 58, p. 1574-1581.

17. Sandoval, Y., Apple, F. S. The Global Need to Define Normality. The 99. percentile Value of Cardiac Troponin. Clin. Chem., 2014, 60, p. 455-462.

18. Jarolim, P. High-sensitivity cardiac troponin assays in the clinical laboratories. Clin. Chem. Lab. Med., 2014, Doi 1515/cclm-2014-0565.

19. Webová adresa: www.ifcc.org. Portál Scientific Division-SD documents.

20. Hickmann, P. E., Lindahl, B., Cullen, L., Koerbin, G., Tate, J., Potter, J. M. Decision limits and the reporting of cardiac troponins: Meeting the needs of both the cardiologist and the ED physician. Crit. Rev. Clin. Lab. Sci., 2014, doi 10.3109/10408363.2014.972497

21. Omland, T., de Lemos, J. A., Holmen, D., Dalen, H., Benth, J. S., Nygard, S. et al. Impact of sex on the prognostic value of high-sensitivity cardiac troponin I in the general population: The HUNT study. Clin. Chem., 2015, 61, p. 646-656.

22. Kramer, C. M. Avoiding the imminent plague of troponinitis.The need for reference limits for high-sensitivity cardiac troponin. J. Am. Coll. Cardiol., 2014, 63, p. 1449-1450.

23. Gore, M. O., Seliger, S. L., de Filippi, R., Nambi, V., Christenson, R. H., Hashim, A. et al. Age-and Sex-Dependent Upper Reference Limits for High-Sensitivity Cardiac Troponin T Assay. J. Am. Coll. Cardiol., 2014, 63 p. 1441-1448.

24. Zeller, T., Ojeda, F., Brunner, F. J., Peitsmeyer, P., Münzel, T., Binder, H. et al. High sensitivity cardiac troponin I in the general population - defining reference populations for the determination of the 99. percentile in the Health Gutenberg Study. Doi10.1515/cclm-2014-0619.

25. Casagranda, I., Cavazza, M., Clerico, A., Galvani, M., Ottani, F., Zaninotto, M. et al. Proposal for the use in emergency departmants of cardiac troponins measured with the latest generation methods in patients with suspected acute coronary syndrome without persistant ST-segment elavation. Clin. Chem. Lab. Med., 2013, 51, p. 1727-1737.

26. Apple, F. S., Hollander, J., Wu, A. H. B., Jaffe, A. S. Improving the 510k FDA process for cardiac troponin assays: In search to common ground. Clin. Chem., 2014, DOI:10.137/clinchem.2014.229286.

27. Aakre, K. M., Langlois, M. R., Barth, J. H., Mista, S., Watine, J., Oosterhuis, W. P. The quality of laboratory aspects of troponin testing in clinical practice guidelines and consensus documents needs to be improved. Clin. Chim. Acta, 2014, 437, p. 58-61.

28. Amundson, B. E., Apple, F. S. Cardiac troponin assays: a review of quantitative point-of-care devices and their efficacy in the diagnosis of myocardial infarction. Clin. Chem. Lab. Med., 2014, Doi 10.1515/cclm-2014-0834.

29. Krintus, M., Kozinski, M., Boundry, P., Capell, N. E., Köller, U., Lackner, K. et al. European multicenter analytical evaluation of the Abbott ARCHITECT STAT high sensitive troponin I immunoassay. Clin. Chem. Lab. Med., 2014, 52, p. 1657-1665.

30. Reid, A. The performance of two high sensitivity troponin methods with low level external quality assessment material. Poster, EFLM Congres Liverpool, November 2014.

31. Yancy, C. W., Jessup, M., Bozkurt, B., Butler, J., Casey, D. E. et al. 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation, 2013,128/16:e240-327.

32. Pudil, R. Troponiny v diagnostice akutních koronárních syndromů – update 2014. Interv. Akut. Kardiol., 2014, 13(1), p. 23–26.

33. Thygesen, K. et al. Third universal definition of myocardial infarction. J. Am. Coll. Cardiol., 2012, 60, p. 1581–1598.

34. Janota, T. Biochemické markery nekrózy myokardu v současné klinické praxi. Interv. Akut. Kardiol., 2013, 12(1), p. 28–33.

35. Hamm, C. W., Bassand, J. P., Argewall, S., Bax, J., Boersma, E. et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur. Heart. J., 2011, 32/23, p. 2999-3054.

36. Reichlin, T. S., Cullen, L., Parsonage, W. A., Greenslade, J., Twerenbold, R., Moehring, B. et al. Two hour algorithm for triage towards rule-out and rule-in of acute myocardial infarction using high-sensitivity cardiac troponin T. Am. J. Med., 2014, doi 10.1016/j.amjmed2014.10.032.

37. Reichlin, T. S., Achindler, C., Drexler, B., Twerenbold, R., Reiter, M., Zellweger, C. et al. One-hour rule-out and rule.in of acute myocardial infarction using high-sensitivity cardiac troponin T. Arch. Intern. Med., 2012, 172, p. 1211-1218.

38. O’Gara, P. T., Kushner, F. G., Ascheim, D. D., Casey, D. E., Chung, M. K. et al. 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction. J. Am. Coll. Cardiol., 2013, 61/4, e78-e140.